Health Sciences Acquisitions Corporation 2
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HSAQ research report →
About the company
Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe.
- CEO
- Roderick Tze Ian Wong
- IPO
- 2020
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $149.23M
- P/E
- -14.01
- P/S
- 4.56
- P/B
- 20266.75
- EV/EBITDA
- -9.93
- Div Yield
- 0.00%
- Gross Margin
- 99.46%
- Op Margin
- -167.96%
- Net Margin
- -167.63%
- ROE
- -158.09%
- ROIC
- -62.63%
- Revenue
- $33.48M · 1169.22%
- Net Income
- $-52,955,000 · 13.22%
- EPS
- $-1.11 · 33.13%
- Op Income
- $-51,807,000
- FCF YoY
- 2.74%
- 52W High
- $13.80
- 52W Low
- $9.41
- 50D MA
- $10.06
- 200D MA
- $9.96
- Beta
- 0.00
- Avg Volume
- 71.38K
Get TickerSpark's AI analysis on HSAQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 19, 23 | Papandreou George | other | 0 |
| Sep 19, 23 | Papandreou George | other | 23,622 |
| Sep 19, 23 | Papandreou George | other | 6,278 |
| Sep 19, 23 | Papandreou George | other | 23,250 |
| Sep 19, 23 | Papandreou George | other | 30,000 |
| Sep 19, 23 | Papandreou George | other | 50,000 |
| Jul 20, 23 | Smith Geoffrey Wade | other | 16,667 |
| Jul 20, 23 | Aryeh Jason | other | 25,000 |
| Jul 20, 23 | Hochman David P | other | 300,000 |
| Jul 20, 23 | Hochman David P | other | 165,000 |
Our HSAQ coverage
Recent articles, reports, and earnings notes.
No research on HSAQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HSAQ report →Similar companies
Peers in the same neighborhood.